Details.
Provides Combivir, Cabenuva, Dovato, Epivir, Epzicom, Juluca, Lexiva, Retrovir, Rukobia, Selzentry, Tivicay and Tivicay PD, Triumeq and Triumeq PD, Trizivir, Viracept, and Ziagen to eligible people. Financial eligibility is listed at 500% of the federal poverty level. Certain products stopped accepting new applications or are being discontinued as noted in the publication.